Comet Biorefining hires Rich Troyer, formerly of Coskata, as CEO

In Canada, Comet Biorefining, has announced the appointment of Rich Troyer as the company’s CEO. Andrew Richard, Comet founder, has been appointed Chairman of the Board and Chief Technology Officer of the company. Troyer was previously the Chief Business Officer at Coskata and also served as a Managing Director at the Blackstone Group where he was responsible for investments in biofuels and bio­chemicals companies. Earlier in his career, he was an equity research analyst at AllianceBernstein, Credit Suisse First Boston, and Piper Jaffray, where he focused on the clean technology and biotechnology sectors. He received an MBA in Finance and Marketing from the Wharton School of the University of Pennsylvania and a BBA degree from Baylor University. Genomatica expands Bioengineering Solutions projects

More on the story.